New chemical strategy boosts accuracy in proteomics
Overlabeling of peptides in proteomics mass spectrometry reduces protein identification and quantitation precision. In proteomics sample preparation, a chemical called N-hydroxysuccinimide, or NHS, is commonly used in tagging proteins to identify proteins for quantitation. However, NHS can also react with other amino acid residues, forming unwanted O-ester derivatives, which bond to oxygen atoms of amino acids such as serine, tyrosine and threonine, complicating analysis. While existing methods, such as hydroxylamine treatment, have been used to reduce excess NHS esters, it is not fully effective, and scientists lack methods to sufficiently remove overlabeled peptides.

Yana Demyanenko and a team of researchers based in the U.K. and Germany published an article in Molecular & Cellular Proteomics, where they developed a methylamine-based method to remove these O-ester modifications. They found that methylamine was the most effective in reducing overlabeled peptides among various tested reagents, such as hydroxylamine, O-methoxylamine HCl, hydrazine hydrate, Tris and ammonium hydroxide. In contrast, standard labeling without quenching led to over 25% overlabeled peptides, while hydroxylamine treatment reduced this to only 10%. Methylamine, however, reduced the overlabeling to less than 1% without affecting the labeling rate or causing additional modifications. Future research will apply this methylamine-based approach to different proteomics workflows to improve peptide identification and quantitation.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Understanding the roles of extracellular matrix and vesicles in valvular disease
MOSAIC scholar Cassandra Clift uses mass spectrometry and multiomics to study cardiovascular calcification and collagen dysregulation, bridging her background in bioengineering and biology to investigate extracellular vesicles and heart disease.

Lipid profiles reveal sex differences in type 2 diabetes
Researchers explored the lipid profiles of individuals with type 2 diabetes and identified potentially useful lipid biomarkers for this condition.

Serum lipids may predict early diabetes risk
Researchers found that levels of two key fatty acids may predict worsening tolerance for glucose, independent of body fat and insulin levels. In turn, these fatty acids may serve as early T2D biomarkers.

Sex and diet shape fat tissue lipid profiles in obesity
Researchers found that sex hormone levels and diet both influence inflammation and lipid composition in obesity.

Mapping the placenta’s hormone network
Study uncovers how the placenta actively metabolizes not only glucocorticoids but also novel androgens and progesterones, reshaping our understanding of pregnancy and its complications.

Biochemists and molecular biologists sweep major 2025 honors
Recent Nobel, MacArthur and Kimberly Prize honorees highlight the power of biochemistry and molecular biology to drive discovery, including immune tolerance, vaccine design and metabolic disease, and to advance medicine and improve human health.